AUROBINDO PHARMA LTD. - Updates

19 Apr 2017

Clarification on news item appeared on CNBC TV18 dated 19th April, 2017 captioned US FDA Issues 5-6 'Largely Procedural' Observations To Aurobindo Pharma's Unit-III'.

Source: BSE India

View all announcements for AUROBINDO PHARMA LTD.

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist